it is recommended that the need for further treatment be occasionally reassessed it appears less effective than its parent compound venlafaxine it is taken by mouth common side effects include dizziness trouble sleeping increased sweating constipation sleepiness anxiety and sexual problems serious side effects may include suicide in those under the age of 25 serotonin syndrome bleeding mania and high blood pressure a withdrawal syndrome may occur if the dose is rapidly decreased it is unclear if use during pregnancy or breastfeeding is safe it is an antidepressant of the serotonin norepinephrine reuptake inhibitor snri class desvenlafaxine was approved for medical use in the united states in 2008 use in europe was declined in 2009 in the united states the wholesale cost is about 25 20 usd per month in 2016 it was the 272nd most prescribed medication in the united states with more than a million prescriptions desvenlafaxine is primarily used as a treatment for major depressive disorder use has only been studied up to 8 weeks it however appears less effective than venlafaxine doses of 50 400 mg day appear effective for major depressive disorder although no additional benefit was demonstrated at doses greater than 50 mg day